Liu et al. [32] concluded that EB1 could act as an oncogene through its involvement in the activation of the WNT signalling pathway in head and neck cancers and Orimo et al. [33] suggested that EB1 might represent a prognostic biomarker in hepatocellular carcinoma. The gene discussed is MAPRE2; the disease is head and neck cancer.